Literature DB >> 35705254

Type I IFN Signaling Is Essential for Preventing IFN-γ Hyperproduction and Subsequent Deterioration of Antibacterial Immunity during Postinfluenza Pneumococcal Infection.

Sunil Palani1, Shruti Bansal2, Atul K Verma1, Christopher Bauer2, Shengjun Shao1, Md Bashir Uddin1, Keer Sun3,2.   

Abstract

Postinfluenza bacterial pneumonia is a significant cause of hospitalization and death in humans. The mechanisms underlying this viral and bacterial synergy remain incompletely understood. Recent evidence indicates that influenza-induced IFNs, particularly type I IFN (IFN-I) and IFN-γ, suppress antibacterial defenses. In this study, we have investigated the relative importance and interplay of IFN-I and IFN-γ pathways in influenza-induced susceptibility to Streptococcus pneumoniae infection. Using gene-deficient mouse models, as well as in vivo blocking Abs, we show that both IFN-I and IFN-γ signaling pathways contribute to the initial suppression of antibacterial immunity; however, IFN-γ plays a dominant role in the disease deterioration, in association with increased TNF-α production and alveolar macrophage (AM) depletion. We have previously shown that IFN-γ impairs AM antibacterial function and thereby acute bacterial clearance. The findings in this study indicate that IFN-γ signaling also impairs AM viability and αβ T cell recruitment during the progression of influenza/S. pneumoniae coinfection. Macrophages insensitive to IFN-γ mice express a dominant-negative mutant IFN-γR in mononuclear phagocytes. Interestingly, macrophages insensitive to IFN-γ mice exhibited significantly improved recovery and survival from coinfection, despite delayed bacterial clearance. Importantly, we demonstrate that IFN-I receptor signaling is essential for preventing IFN-γ hyperproduction and animal death during the progression of postinfluenza pneumococcal pneumonia.
Copyright © 2022 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35705254      PMCID: PMC9247018          DOI: 10.4049/jimmunol.2101135

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.426


  38 in total

1.  Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia.

Authors:  Julie L McAuley; Felicita Hornung; Kelli L Boyd; Amber M Smith; Raelene McKeon; Jack Bennink; Jonathan W Yewdell; Jonathan A McCullers
Journal:  Cell Host Microbe       Date:  2007-10-11       Impact factor: 21.023

2.  Influenza infection leads to increased susceptibility to subsequent bacterial superinfection by impairing NK cell responses in the lung.

Authors:  Cherrie-Lee Small; Christopher R Shaler; Sarah McCormick; Mangalakumari Jeyanathan; Daniela Damjanovic; Earl G Brown; Petra Arck; Manel Jordana; Charu Kaushic; Ali A Ashkar; Zhou Xing
Journal:  J Immunol       Date:  2010-01-18       Impact factor: 5.422

3.  Effects of Influenza on Alveolar Macrophage Viability Are Dependent on Mouse Genetic Strain.

Authors:  Danielle Califano; Yoichi Furuya; Dennis W Metzger
Journal:  J Immunol       Date:  2018-05-14       Impact factor: 5.422

4.  Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection.

Authors:  Keer Sun; Dennis W Metzger
Journal:  Nat Med       Date:  2008-04-27       Impact factor: 53.440

5.  Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice.

Authors:  Arash Shahangian; Edward K Chow; Xiaoli Tian; Jason R Kang; Amir Ghaffari; Su Y Liu; John A Belperio; Genhong Cheng; Jane C Deng
Journal:  J Clin Invest       Date:  2009-07       Impact factor: 14.808

6.  Type I interferon limits influenza virus-induced acute lung injury by regulation of excessive inflammation in mice.

Authors:  Yojiro Arimori; Risa Nakamura; Hisakata Yamada; Kensuke Shibata; Naoyoshi Maeda; Tetsuo Kase; Yasunobu Yoshikai
Journal:  Antiviral Res       Date:  2013-05-28       Impact factor: 5.970

7.  Influenza "Trains" the Host for Enhanced Susceptibility to Secondary Bacterial Infection.

Authors:  Kari Ann Shirey; Darren J Perkins; Wendy Lai; Wei Zhang; Lurds R Fernando; Fabian Gusovsky; Jorge C G Blanco; Stefanie N Vogel
Journal:  mBio       Date:  2019-05-07       Impact factor: 7.867

8.  Bacterial pneumonia and pandemic influenza planning.

Authors:  Ravindra K Gupta; Robert George; Jonathan S Nguyen-Van-Tam
Journal:  Emerg Infect Dis       Date:  2008-08       Impact factor: 6.883

Review 9.  A Positive Feedback Amplifier Circuit That Regulates Interferon (IFN)-Stimulated Gene Expression and Controls Type I and Type II IFN Responses.

Authors:  Agata Michalska; Katarzyna Blaszczyk; Joanna Wesoly; Hans A R Bluyssen
Journal:  Front Immunol       Date:  2018-05-28       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.